Kellett Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Kellett Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,579	Closed	-$248K	–	72
2024 Q1	$248K	Hold	4,579	–	–	0.17%	71
2023 Q4	$235K	Sell	4,579 -500	-10%	-$26.2K	0.17%	68
2023 Q3	$295K	Buy	5,079 +693	+16%	+$42.5K	0.25%	43
2023 Q2	$281K	Hold	4,386	–	–	0.25%	43
2023 Q1	$304K	Hold	4,386	–	–	0.29%	38
2022 Q4	$316K	Hold	4,386	–	–	0.31%	37
2022 Q3	$340K	Buy	4,386 +5	+0.1%	+$363	0.41%	32
2022 Q2	$337K	Buy	+4,381	New	+$334K	0.44%	32

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kellett Wealth Advisors's BMY Position: Q2 2024 in Review

Kellett Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 4,579 shares — an estimated $248K sold.

Kellett Wealth Advisors first reported a position in BMY in Q2 2022 and held it in 8 quarters. The position peaked at $340K in Q3 2022. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Kellett Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Kellett Wealth Advisors sold 4,579 Bristol-Myers Squibb shares in Q2 2024, an estimated $248K.
Kellett Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 8 quarters.
Kellett Wealth Advisors's Bristol-Myers Squibb position peaked at $340K in Q3 2022.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Kellett Wealth Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.